Article
Folate receptor targeted nanoparticles containing niraparib and doxorubicin for treatment…
medRxiv · 2022 · Lucy Wang
Key facts
| Title | Folate receptor targeted nanoparticles containing niraparib and doxorubicin for treatment of high grade serous ovarian cancer |
|---|---|
| First author | Lucy Wang |
| Journal | medRxiv |
| Published | Sep 1, 2022 |
| DOI | 10.1101/2022.08.29.505711 |
| Devices mentioned | K060774 |
| Product codes mentioned | CGN, KIE |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1